Prosight Management as of June 30, 2022
Portfolio Holdings for Prosight Management
Prosight Management holds 24 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Galapagos Nv Spon Adr (GLPG) | 16.2 | $21M | 369k | 55.80 | |
| Prothena Corp SHS (PRTA) | 11.8 | $15M | 550k | 27.15 | |
| Kezar Life Sciences (KZR) | 8.2 | $10M | 1.3M | 8.27 | |
| Albireo Pharma | 7.3 | $9.3M | 468k | 19.86 | |
| Kalvista Pharmaceuticals (KALV) | 6.4 | $8.1M | 821k | 9.84 | |
| Aldeyra Therapeutics (ALDX) | 6.2 | $7.9M | 2.0M | 3.99 | |
| Meiragtx Holdings (MGTX) | 5.9 | $7.5M | 986k | 7.57 | |
| Charles River Laboratories (CRL) | 4.6 | $5.9M | 28k | 213.96 | |
| 1life Healthcare | 4.5 | $5.7M | 725k | 7.84 | |
| Quidel Corp (QDEL) | 3.6 | $4.5M | 47k | 97.17 | |
| Shattuck Labs (STTK) | 3.3 | $4.1M | 1.0M | 4.06 | |
| Cue Biopharma (CUE) | 3.2 | $4.1M | 1.7M | 2.49 | |
| Rocket Pharmaceuticals (RCKT) | 3.0 | $3.8M | 277k | 13.76 | |
| 1life Healthcare Call Call Option | 2.7 | $3.4M | 440k | 7.84 | |
| Global Blood Therapeutics In | 2.6 | $3.3M | 102k | 31.95 | |
| Mirum Pharmaceuticals (MIRM) | 2.5 | $3.1M | 162k | 19.46 | |
| Tenet Healthcare Corp Com New (THC) | 2.1 | $2.7M | 51k | 52.56 | |
| BioCryst Pharmaceuticals (BCRX) | 1.5 | $1.9M | 177k | 10.58 | |
| Silverback Therapeutics (SPRY) | 1.1 | $1.4M | 341k | 4.24 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 1.0 | $1.3M | 1.7M | 0.78 | |
| Ardelyx (ARDX) | 1.0 | $1.3M | 2.2M | 0.59 | |
| Inmode SHS (INMD) | 0.8 | $1.0M | 45k | 22.40 | |
| Apollo Endosurgery | 0.3 | $329k | 90k | 3.65 | |
| Cognition Therapeutics (CGTX) | 0.2 | $254k | 120k | 2.11 |
